/

Research

UK PSYCHEDELIC TRIALS START-UP ISSUES NATIONAL CALL FOR VOLUNTEERS TO TRIAL INNOVATIVE MEDICINES FOR MENTAL HEALTH DISORDERS

UK Psychedelic Trials Start-Up Issues National Call for Volunteers to Trial Innovative Medicines for Mental Health Disorders

Clerkenwell Health is today issuing a national call for volunteers to step forward for upcoming trials testing psychedelic drugs.

New Paper Explores How People Process Emotions on Antidepressants vs. Psilocybin

When specific brain areas important for emotions were examined, escitalopram had a more substantial impact on reducing their activity. These regions of the brain became less active in the escitalopram group after treatment, which may explain why individuals taking escitalopram felt less intense emotions.
Psilocybin May Be More Cost-Effective than Current Treatments for Depression, Major New Study Findsnastazia

Psilocybin May Be More Cost-Effective than Current Treatments for Depression, Major New Study Finds

Psilocybin-based treatment combined with therapy may provide more cost-effective solution to treating Major Depressive Disorder than methods such as CBT.

New Study Reveals Microdosing Could Make You Feel More Authentic

,
A new study shows that microdosing could make you feel more authentic and cause you to have greater satisfaction in your daily life.
The Biggest Psychedelic News Stories of the Week – June 30

The Biggest Psychedelic News Stories of the Week – June 30

,
In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity and acceptance.
The FDA Issues Guidance on Designing Psychedelic Clinical Trials

The FDA Issues Guidance on Designing Psychedelic Clinical Trials

The Food and Drug Administration published a new draft guidance with the purpose to advise researchers on study design when investigating the potential of psychedelics.
Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery

Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery

,
Ibogaine’s anti-addictive properties are known to work wonders on people struggling with various substances, such as cocaine, amphetamines, alcohol, nicotine and more.
Guide to Ibogaine - The Ibogaine Experience, Benefits & Side Effects

Guide to Ibogaine – The Ibogaine Experience, Benefits & Side Effects

,
This article aims to provide a comprehensive exploration of ibogaine, shedding light on its pharmacological mechanisms, potential therapeutic applications, benefits, risks, and the ethical considerations surrounding its use.
The Biggest Psychedelic News Stories of the Week – June 23

The Biggest Psychedelic News Stories of the Week – June 23

,
New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research on the benefits of ibogaine to treat opioid addiction. Ayahuasca played a key role in finding Colombian children stranded in the Amazonian jungle.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.